LONDON, UK, 4 May 2007 - SkyePharma PLC (the “Company”) (LSE: SKP; Nasdaq: SKYE) announces the results of the voting by shareholders at the Extraordinary General Meeting held earlier today. The resolution approving the SkyePharma PLC 2007 Long-Term Incentive Plan (the “LTIP”) was passed.
